(ER), progesterone receptor (PR) and HER2, breast cancer can be classified into two categories (4). For the first category, at least one of these receptors is positive. Selective ER inhibitors, such as Tamoxifen, and PR inhibitors, such as Mifepristone, are widely used in the clinical ...